42298 Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices 

7These recommended changes include: 

(i) Extending the annual resolution plan filing 

cycle to a two-year cycle; 

(ii) providing additional clarity on filing 

deadlines; 

(iii) requiring that any agency guidance be 

provided more than 12 months in advance of each 

filing deadline; 

(iv) allowing firms to satisfy some of their 

Regulation QQ requirements by incorporating their 

IDI plans by reference; 

(v) providing for further tailoring based on the 

systemic risk posed by each firm, 

(vi) further reducing the need for duplicative 

reporting; 

(vii) adjusting the forecasting expected from the 

firms; 

(viii) providing greater guidance regarding 

regulatory expectations related to the resolution of 

financial market utilities; 

(ix) eliminating the strategic analysis section from 

tailored plans; 

(x) providing an opportunity for notice and 

comment on any new information requirements, the 

framework used for assessing resolution plans, and 

the procedures related to remediation; 

(xi) requiring the agencies to provide feedback on 

plans within six months of plan submission; 

(xii) refraining from making feedback provided to 

the firms public or providing firms more time to 

consider the feedback before it is made public; and 

(xiii) reconsidering the procedures the Board and 

FDIC undertake to engage with firms. 

8See 12 U.S.C. 5365(d)(8) (requiring the Board 

and FDIC to issue joint rules implementing the 

Dodd-Frank Act’s resolution planning 

requirements), 12 CFR. Part 243 (the Board’s 

resolution planning rule), and 12 CFR. Part 381 (the 

FDIC’s resolution planning rule). Aspects of the 

statute and regulations require joint actions or 

determinations by the Board and FDIC and 

therefore the agencies have jointly developed a 

coordinated resolution plan review process. 

Current actions: On January 22, 2018 

the Board published a notice in the 

Federal Register (83 FR 2983) 

requesting public comment for 60 days 

on the extension, with revision, of the 

Reporting Requirements Associated 

with Resolution Plans (Regulation QQ). 

The revision to the clearance is burden 

increase due to a reassessment of the 

burden hours associated with 

responding to the informational 

requirements of Regulation QQ and to 

guidance, feedback, and additional 

requests for information by the agencies 

as part of the iterative resolution 

planning process. The increase in 

burden is mitigated by the 

postponement of the July 2018 

submission date for the resolution plans 

of the complex domestic filers, which 

account for the largest percentage of 

overall burden hours. The comment 

period for this notice expired on March 

23, 2018. The Board received one 

comment on the proposal. The 

commenter recommended a number of 

potential changes to Regulation QQ 

intended to enhance the quality of the 

information collected pursuant to the 

regulation and reduce the burden of the 

information collection requirements.7

The Board is not adopting any of the 

recommended changes at this time. 

Either a revision to the Board’s 

Regulation QQ or joint action with the 

FDIC would be necessary to implement 

each of the recommended changes. Most 

of the recommendations would require 

changes to the Board’s Regulation QQ, 

which could only be accomplished 

pursuant to a rulemaking. In addition, 

the Board could not unilaterally take the 

actions requested by these comments, 

even those that would not require a 

rulemaking, as they fall under the 

purview of a rule that the Board 

proposed jointly with the FDIC and a 

process that is jointly administered by 

the two agencies.8 However, the Board 

will consider the recommended changes 

in due course as it determines, in 

consultation with the FDIC, whether to 

conduct a joint rulemaking. The 

revisions will be implemented as 

proposed. 

Board of Governors of the Federal Reserve 

System, August 15, 2018. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2018–17964 Filed 8–20–18; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities 

The companies listed in this notice 

have given notice under section 10 of 

the Home Owners’ Loan Act (12 U.S.C. 

1467a) (HOLA) and Regulation LL, (12 

CFR part 238) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 238.53 of Regulation 

LL (12 CFR 225.53). Unless otherwise 

noted, these activities will be conducted 

throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 10(c)(4)(B) 

of the HOLA 12 U.S.C. 1467a(c)(4)(B). 

Unless otherwise noted, comments 

regarding the notices must be received 

at the Reserve Bank indicated or the 

offices of the Board of Governors not 

later than September 4, 2018. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. McHenry Bancorp, Inc., McHenry, 

Illinois; to engage de novo in purchasing 

and servicing loans, and holding and 

managing improved real estate, 

pursuant to sections 238.53(b)(1) and (8) 

of Regulation LL. 

Board of Governors of the Federal Reserve 

System, August 16, 2018. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2018–17975 Filed 8–20–18; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than September 18, 

2018. 

A. Federal Reserve Bank of Dallas 

(Robert L. Triplett III, Senior Vice 

President) 2200 North Pearl Street, 

Dallas, Texas 75201–2272: 

1. Woodforest Financial Group 

Employee Stock Ownership Plan, The 

Woodlands, Texas; and Woodforest 

Financial Group Employee Stock 

Ownership Trust, Spring, Texas; to 

acquire up to an additional 28 percent 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices 42299 

of Woodforest Financial Group, Inc., 

The Woodlands, Texas, and thereby 

indirectly acquire Woodforest National 

Bank, Houston, Texas. 

Board of Governors of the Federal Reserve 

System, August 16, 2018. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2018–17974 Filed 8–20–18; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60-Day–18–0210; Docket No. CDC–2018– 

0069] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

continuing information collection 

project titled List of Ingredients Added 

to Tobacco in the Manufacture of 

Cigarette Products. 

DATES: CDC must receive written 

comments on or before October 22, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0069 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(egulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffery M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

List of Ingredients Added to Tobacco 

in the Manufacture of Cigarette 

Products—Extension (OMB# 0920–0210 

Exp.Date 12/31/2018)—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Cigarette smoking is the leading 

preventable cause of premature death 

and disability in our Nation. Each year 

more than 480,000 deaths occur as the 

result of cigarette smoking-related 

diseases. 

The CDC’s Office on Smoking and 

Health (OSH) has the primary 

responsibility for the HHS smoking and 

health program. Since 1986, as required 

by the Comprehensive Smoking 

Education Act (CSEA) of 1984, which 

amended the Federal Cigarette Labeling 

and Advertising Act, 15 U.S.C. 1335a, 

CDC has collected information about the 

ingredients used in cigarette products. 

HHS has delegated responsibility for 

implementing the required information 

collection to CDC’s OSH. Respondents 

are commercial cigarette manufacturers, 

packagers, or importers (or their 

representatives), who are required by 

the CSEA to submit ingredient reports to 

HHS on an annual basis. 

Respondents are not required to 

submit specific forms; however, they are 

required to submit a list of all 

ingredients used in their products. CDC 

requires the ingredient report to be 

submitted by chemical name and 

Chemical Abstract Service (CAS) 

Registration Number, consistent with 

accepted reporting practices for other 

companies currently required to report 

ingredients added to other consumer 

products. The information collected is 

subject to strict confidentiality 

provisions. 

Ingredient reports are due annually on 

March 31. Information is submitted to 

CDC by mailing or faxing a written 

report on the respondent’s letterhead. 

All faxed lists should be followed up 

with a mailed original. Data may also be 

submitted to CDC by CD, three-inch 

floppy disk, or thumb drive. Electronic 

mail submissions are not accepted. Mail 

Annual Ingredient Submissions to 

Attention: FCLAA Program Manager, 

Office on Smoking and Health, National 

Center for Chronic Disease Prevention 

and Health Promotion, Centers for 

Disease Control and Prevention, 4770 

Buford Highway, NE, MS S107–7, 

Atlanta, GA 30341–3717 

Upon receipt and verification of the 

annual ingredient report, CDC issues a 

Certificate of Compliance to the 

respondent. As deemed appropriate by 

the Secretary of HHS, HHS is authorized 

to use the information to report to 

Congress the health effects of 

ingredients, research activities related to 

the health effects of ingredients, and 

other information that the Secretary 

determines to be of public interest. 

There are no costs to respondents other 


sradovich on DSK3GMQ082PROD with NOTICES